Skrining Kolesterol Total dan HDL sebagai Upaya Deteksi Dini Risiko Penyakit Kardiovaskular pada Populasi Dewasa melalui Kegiatan Pengabdian Masyarakat di Kelurahan Semanan
DOI:
https://doi.org/10.58812/jpws.v5i07.3557Kata Kunci:
HDL, Kolesterol Total, Pengabdian Kepada Masyarakat, Profil Lipid, Risiko KardiovaskularAbstrak
Penyakit kardiovaskular merupakan salah satu penyebab utama morbiditas dan mortalitas, sehingga deteksi dini faktor risiko perlu dilakukan melalui kegiatan pengabdian kepada masyarakat. Kegiatan ini bertujuan menggambarkan profil risiko kardiovaskular berdasarkan rasio kolesterol total terhadap High Density Lipoprotein (HDL) pada 155 peserta yang menjalani pemeriksaan profil lipid. Data yang dikumpulkan meliputi usia, jenis kelamin, kadar kolesterol total, kadar HDL, dan rasio kolesterol total/HDL. Rerata usia peserta adalah 46,49 ± 10,29 tahun dengan mayoritas perempuan (70,3%). Rerata kadar kolesterol total sebesar 209,97 ± 39,59 mg/dL, kadar HDL 50,60 ± 7,76 mg/dL, dan rasio kolesterol total/HDL 4,41 ± 2,00. Berdasarkan kategori risiko, 22,6% peserta termasuk optimal, 56,1% average risk, dan 21,3% high risk. Peningkatan rasio kolesterol total/HDL ditemukan seiring peningkatan kategori risiko pada kedua jenis kelamin. Temuan ini menunjukkan bahwa sebagian besar peserta memiliki risiko kardiovaskular sedang hingga tinggi. Oleh karena itu, skrining profil lipid dan edukasi gaya hidup sehat perlu dilakukan secara berkelanjutan sebagai upaya pencegahan penyakit kardiovaskular di masyarakat.
Referensi
Abera, A., Worede, A., Hirigo, A. T., Alemayehu, R., & Ambachew, S. (2024). Dyslipidemia and associated factors among adult cardiac patients: a hospital-based comparative cross-sectional study. European Journal of Medical Research, 29(1), 237. https://doi.org/10.1186/s40001-024-01802-x
Ali, N., Samadder, M., Kathak, R. R., & Islam, F. (2023). Prevalence and factors associated with dyslipidemia in Bangladeshi adults. PLOS ONE, 18(1), e0280672. https://doi.org/10.1371/journal.pone.0280672
Arvanitis, M., & Lowenstein, C. J. (2023). Dyslipidemia. Annals of Internal Medicine, 176(6), ITC81–ITC96. https://doi.org/10.7326/AITC202306200
Assmann, G., & Gotto, A. M. (2004). HDL Cholesterol and Protective Factors in Atherosclerosis. Circulation, 109(23_suppl_1). https://doi.org/10.1161/01.CIR.0000131512.50667.46
Elshazly, M. B., Nicholls, S. J., Nissen, S. E., St. John, J., Martin, S. S., Jones, S. R., Quispe, R., Stegman, B., Kapadia, S. R., Tuzcu, E. M., & Puri, R. (2016). Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events. The American Journal of Cardiology, 118(5), 647–655. https://doi.org/10.1016/j.amjcard.2016.06.021
Flores Soler, J., Vila Costa, I., Bengoa Terrero, C., Fernandez Perez, C., Garcia Gonzalez, F., Bas Villalobos, M., Perez-Villacastin Dominguez, J., & Villares, J. (2024). Prevecardio: a single-visit population screening model for detection and prevention of 10-year cardiovascular risk. European Heart Journal, 45(Supplement_1). https://doi.org/10.1093/eurheartj/ehae666.3606
Gebreegziabiher, G., Belachew, T., Mehari, K., & Tamiru, D. (2021). Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia. PLOS ONE, 16(2), e0243103. https://doi.org/10.1371/journal.pone.0243103
Li, Z., Zhu, G., Chen, G., Luo, M., Liu, X., Chen, Z., & Qian, J. (2022). Distribution of lipid levels and prevalence of hyperlipidemia: data from the NHANES 2007–2018. Lipids in Health and Disease, 21(1), 111. https://doi.org/10.1186/s12944-022-01721-y
López-Bueno, R., Núñez-Cortés, R., Calatayud, J., Salazar-Méndez, J., Petermann-Rocha, F., López-Gil, J. F., & del Pozo Cruz, B. (2024). Global prevalence of cardiovascular risk factors based on the Life’s Essential 8 score: an overview of systematic reviews and meta-analysis. Cardiovascular Research, 120(1), 13–33. https://doi.org/10.1093/cvr/cvad176
Mansencal, D., Mansencal, N., Miliani, K., Toussaint, A., Pépin, M., Beauchet, A., Prati, G., Boisson de Chazournes, P., Levesque, T., Weizman, O., Rodon, C., Josseran, L., Dubourg, O., & Hauguel-Moreau, M. (2025). Association of menopausal status and menopausal hormone therapy with cardiovascular risk factors prevalence in a large French urban population. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwaf460
Palmisano, B. T., Zhu, L., Eckel, R. H., & Stafford, J. M. (2018). Sex differences in lipid and lipoprotein metabolism. Molecular Metabolism, 15, 45–55. https://doi.org/10.1016/j.molmet.2018.05.008
Pownall, H. J., Rosales, C., Gillard, B. K., & Gotto, A. M. (2021). High-density lipoproteins, reverse cholesterol transport and atherogenesis. Nature Reviews Cardiology, 18(10), 712–723. https://doi.org/10.1038/s41569-021-00538-z
Riutord-Sbert, P., Tárraga López, P. J., López-González, Á. A., Coll Campayo, I., Busquets-Cortés, C., & Ramírez Manent, J. I. (2025). Determinants of Atherogenic Dyslipidemia and Lipid Ratios: Associations with Sociodemographic Profile, Lifestyle, and Social Isolation in Spanish Workers. Journal of Clinical Medicine, 14(19), 7039. https://doi.org/10.3390/jcm14197039
Stevenson, J. C., Tsiligiannis, S., & Panay, N. (2019). Cardiovascular Risk in Perimenopausal Women. Current Vascular Pharmacology, 17(6), 591–594. https://doi.org/10.2174/1570161116666181002145340
Svendsen, K., Jacobs Jr, D. R., Røyseth, I. T., Garstad, K. W., Byfuglien, M. G., Granlund, L., Mørch-Reiersen, L. T., Telle-Hansen, V. H., & Retterstøl, K. (2019). Community pharmacies offer a potential high-yield and convenient arena for total cholesterol and CVD risk screening. European Journal of Public Health, 29(1), 17–23. https://doi.org/10.1093/eurpub/cky190
Tan, K. (2016). Re‐examining the high‐density lipoprotein hypothesis. Journal of Diabetes Investigation, 7(4), 445–447. https://doi.org/10.1111/jdi.12487
Wan, H., Wu, H., Wei, Y., Wang, S., & Ji, Y. (2025). Novel lipid profiles and atherosclerotic cardiovascular disease risk: insights from a latent profile analysis. Lipids in Health and Disease, 24(1), 71. https://doi.org/10.1186/s12944-025-02471-3
Xu, D., Xie, L., Cheng, C., Xue, F., & Sun, C. (2024). Triglyceride-rich lipoproteins and cardiovascular diseases. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1409653
Zhou, D., Liu, X., Lo, K., Huang, Y., & Feng, Y. (2022). The effect of total cholesterol/high-density lipoprotein cholesterol ratio on mortality risk in the general population. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.1012383
Unduhan
Diterbitkan
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2026 Alexander Halim Santoso, Bryan Anna Wijaya
Artikel ini berlisensiCreative Commons Attribution-ShareAlike 4.0 International License.
Facebook 
Instagram 
Twitter 
Youtube 
westscience.journals@gmail.com